MedTrace Logo

Radiotherapy of Head and Neck Cancer With SIB

NCT06831903 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2025-02-18

No results posted yet for this study

Summary

Title: Simultaneous Integrated Boost in Primary and Adjuvant Therapy of Head and Neck Tumors: Quality Control Registry Prospective Longitudinal Observational Study

Short Title: Radiotherapy for Head and Neck Tumors with SIB

Objective: To evaluate the efficacy and safety of definitive and adjuvant radio(chemo)therapy with simultaneous integrated boost (SIB) in patients with head and neck cancers. The study aims to assess local and regional control, overall survival, metastasis-free survival, therapy-related toxicities, and quality of life.

Study Design: A prospective, longitudinal, non-interventional registry study documenting real-world outcomes and quality measures of therapy applied according to existing clinical guidelines.

Conditions

  • Quality of Life (QOL)
  • Head and Neck Cancer
  • Radiotherapy Side Effect
  • Radiotherapy, Conformal (IMRT)

Sponsors & Collaborators

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Victor Lewitzki, MD, PhD · University Clinic of Wuerzburg, Department of Radiation Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-21
Primary Completion
2034-10-01
Completion
2039-10-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06831903 on ClinicalTrials.gov